SUPPLEMENT

Q3 2022 — Income statement trends

Q3 2022PDF · 2 pages143 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q320 	Q420 	Q121 	Q221 	Q321 	Q421 	Q122 	Q222 	Q322
Revenues:
Clearing and transaction fees 	835.4 	843.0 	1,007.0 	929.9 	878.9 	949.3 	1,138.1 	1,024.6 	998.6
Market data and information services 	139.4 	139.8 	144.2 	145.2 	145.4 	142.1 	151.7 	151.7 	154.3
Other Revenue 	105.9 	115.7 	102.1 	104.1 	85.6 	55.9 	56.8 	60.9 	74.9
Total revenues 	1,080.7 	1,098.5 	1,253.3 	1,179.2 	1,109.9 	1,147.3 	1,346.6 	1,237.2 	1,227.8
Expenses:
Compensation and benefits 	216.4 	215.6 	225.0 	211.7 	198.6 	201.7 	185.2 	185.3 	189.6
Technology 	48.1 	53.6 	48.2 	49.3 	49.3 	45.8 	45.9 	45.9 	46.8
Professional fees and outside services 	48.4 	50.0 	37.4 	36.8 	45.2 	32.3 	31.8 	32.0 	35.1
Amortization of purchased intangibles 	78.3 	79.0 	60.6 	59.4 	59.0 	58.6 	58.4 	57.1 	55.5
Depreciation and amortization 	39.7 	41.5 	37.6 	37.1 	37.2 	35.9 	33.5 	33.0 	34.5
Licensing and other fee agreements 	57.7 	57.9 	64.7 	54.2 	57.6 	60.4 	80.9 	83.1 	83.6
Other expense 	67.1 	85.9 	54.7 	56.0 	49.3 	80.9 	51.8 	51.1 	43.9
Operating expenses 	555.7 	583.5 	528.2 	504.5 	496.2 	515.6 	487.5 	487.5 	489.0
Operating Income 	525.0 	515.0 	725.1 	674.7 	613.7 	631.7 	859.1 	749.7 	738.8
Operating Margin 	49% 	47% 	58% 	57% 	55% 	55% 	64% 	61% 	60%
Non-operating Income and Expense
Investment income 	23.6 	31.1 	30.9 	62.4 	145.8 	67.8 	73.1 	286.9 	686.2
Interest and other borrowing costs 	(41.7) 	(41.7) 	(41.5) 	(41.7) 	(41.8) 	(41.9) 	(42.5) 	(39.9) 	(40.4)
Equity in net gains (losses) of unconsolidated subsidiaries 	44.0 	46.6 	56.2 	55.7 	66.4 	67.5 	73.3 	87.3 	76.5
Other non-operating income (expense) 	(14.4) 	(16.0) 	(18.4) 	(25.0) 	311.8 	74.2 	(46.7) 	(217.3) 	(581.1)
Non-operating income (expense) 	11.5 	20.0 	27.2 	51.4 	482.2 	167.6 	57.2 	117.0 	141.2
Income before income taxes 	536.5 	535.0 	752.3 	726.1 	1,095.9 	799.3 	916.3 	866.7 	880.0
Income taxes 	125.0 	110.2 	177.5 	215.5 	169.6 	174.1 	205.3 	204.2 	200.4
Net income 	411.5 	424.8 	574.8 	510.6 	926.3 	625.2 	711.0 	662.5 	679.6
Less: net income (loss) attributable to NCI 	(0.2) 	0.8 	0.4 	0.3 	(0.2) 	- 	- 	-
Net Income Attributable to CME Group 	411.7 	424.0 	574.4 	510.3 	926.5 	625.2 	711.0 	662.5 	679.6
Net Income Attributable to CME Group 	411.7 	424.0 	574.4 	510.3 	926.5 	613.3 	702.0 	654.1 	671.1
Effective Tax Rate 	23.3% 	20.6% 	23.6% 	29.7% 	15.5% 	21.8% 	22.4% 	23.6% 	22.8%
Earnings per Share:
Basic EPS 	1.15 	1.18 	1.60 	1.42 	2.59 	1.71 	1.96 	1.82 	1.87
Diluted EPS 	1.15 	1.18 	1.60 	1.42 	2.58 	1.71 	1.95 	1.82 	1.87
Weighted average number of common stock shares:
Basic Shares 	357,791 	358,047 	358,147 	358,261 	358,363 	358,582 	358,609 	358,641 	358,715
Diluted Shares 	358,590 	358,612 	358,817 	358,888 	358,988 	359,019 	359,180 	359,205 	359,288
Preferred Shares 	2,890 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q320 	Q420 	Q121 	Q221 	Q321 	Q421 	Q122 	Q222 	Q322
Revenues:
Clearing and transaction fees 	835.4 	843.0 	1,007.0 	929.9 	878.9 	949.3 	1,138.1 	1,024.6 	998.6
Market data and information services 	139.4 	139.8 	144.2 	145.2 	145.4 	142.1 	151.7 	151.7 	154.3
Other Revenue 	105.9 	115.7 	102.1 	101.0 	85.6 	55.9 	56.8 	60.9 	74.9
Total revenues 	1,080.7 	1,098.5 	1,253.3 	1,176.1 	1,109.9 	1,147.3 	1,346.6 	1,237.2 	1,227.8
Expenses:
Compensation and benefits 	205.5 	202.6 	207.5 	201.9 	191.1 	183.7 	182.8 	189.5 	189.1
Technology 	47.3 	52.2 	47.7 	49.2 	49.1 	45.6 	45.8 	45.9 	46.8
Professional fees and outside services 	40.0 	39.2 	27.9 	30.0 	26.5 	27.2 	30.3 	31.4 	35.1
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	37.0 	37.2 	36.8 	36.7 	36.7 	35.6 	33.5 	32.9 	33.8
Licensing and other fee agreements 	57.7 	57.9 	64.7 	54.2 	57.6 	60.4 	80.9 	83.1 	81.9
Other expense 	56.1 	74.3 	52.1 	54.8 	51.3 	76.5 	51.7 	59.6 	54.4
Operating expenses 	443.6 	463.4 	436.7 	426.8 	412.3 	429.0 	425.0 	442.4 	441.1
Operating Income 	637.1 	635.1 	816.6 	749.3 	697.6 	718.3 	921.6 	794.8 	786.7
Operating Margin 	59% 	58% 	65% 	64% 	63% 	63% 	68% 	64% 	64%
Non-operating Income and Expense
Investment income 	22.6 	24.1 	26.9 	37.3 	55.1 	58.2 	74.7 	299.5 	688.5
Interest and other borrowing costs 	(41.7) 	(41.7) 	(41.5) 	(41.7) 	(41.8) 	(41.9) 	(42.5) 	(39.9) 	(40.4)
Equity in net gains (losses) of unconsolidated subsidiaries 	44.0 	46.6 	56.2 	55.7 	70.5 	78.7 	84.7 	98.2 	89.6
Other non-operating income (expense) 	(14.4) 	(16.0) 	(18.4) 	(25.0) 	(32.9) 	(33.0) 	(43.4) 	(218.5) 	(585.7)
Non-operating income (expense) 	10.5 	13.0 	23.2 	26.3 	50.9 	62.0 	73.5 	139.3 	152.0
Income before income taxes 	647.6 	648.1 	839.8 	775.6 	748.5 	780.3 	995.1 	934.1 	938.7
Income taxes 	152.8 	150.2 	198.2 	186.7 	174.3 	172.8 	228.9 	217.6 	219.6
Net income 	494.8 	497.9 	641.6 	588.9 	574.2 	607.5 	766.2 	716.5 	719.1
Less: net income (loss) attributable to NCI 	(0.2) 	0.8 	0.4 	0.3 	(0.2) 	- 	- 	-
Net Income Attributable to CME Group 	495.0 	497.1 	641.2 	588.6 	574.4 	607.5 	766.2 	716.5 	719.1
Net Income Attributable to Common Shareholders of CME Group 	495.0 	497.1 	641.2 	588.6 	574.4 	595.7 	756.6 	707.5 	710.0
Effective Tax Rate 	23.6% 	23.2% 	23.6% 	24.1% 	23.3% 	22.1% 	23.0% 	23.3% 	23.4%
Earnings per Share:
Basic EPS 	1.38 	1.39 	1.79 	1.64 	1.60 	1.66 	2.11 	1.97 	1.98
Diluted EPS 	1.38 	1.39 	1.79 	1.64 	1.60 	1.66 	2.11 	1.97 	1.98
Weighted average number of common stock shares:
Basic Shares 	357,791 	358,047 	358,147 	358,261 	358,363 	358,582 	358,609 	358,641 	358,715
Diluted Shares 	358,590 	358,612 	358,817 	358,888 	358,988 	359,019 	359,180 	359,205 	359,288
Preferred Shares 	- 	- 	- 	- 	- 	2,890 	4,584 	4,584 	4,584

-- 2 of 2 --